美国全国医生调查:老年2型糖尿病患者降糖药物减量与转换策略
该全国性调查纳入445名美国内科、老年医学及内分泌科医生,评估其在健康良好(HbA1c 6.3%)、健康复杂(HbA1c 7.3%)、健康较差(HbA1c 7.7%)三种场景下对引起低血糖药物的减量/停药或转换决策。结果显示,三种场景中分别有48%、4%和20%的医生选择减量,17%的医生选择换药且各健康状态间无显著差异。半数医生为健康复杂或较差的老年患者设定的HbA1c目标低于指南推荐。
要点
- 健康良好、复杂、较差三场景中分别有48%、4%、20%的医生对引起低血糖药物减量。
- 17%的医生选择换药,且不同患者健康状态间无显著差异。
- 半数医生为健康复杂或较差的老年患者设定的HbA1c目标低于指南推荐。
核心结论
- 多数美国医生不会在指南推荐的HbA1c目标范围内对引起低血糖的药物进行减量或转换。
- 医生偏好低于指南的HbA1c目标,这一偏好需要被解决以优化减量决策。
研究设计与样本
- 研究为全国性调查,对象为美国普通内科、老年医学或内分泌科的医生。
- 调查设置三种场景:健康良好且HbA1c 6.3%、健康复杂且HbA1c 7.3%、健康较差且HbA1c 7.7%。
- 共445名符合条件的应答者,应答率37.5%。
主要发现
- 健康良好、健康复杂、健康较差场景中,分别有48%、4%、20%的医生对引起低血糖的药物进行减量。
- 总体有17%的医生选择换药,不同患者健康状态间无显著差异。
- 半数医生为健康复杂或健康较差的老年患者选择的HbA1c目标低于指南推荐。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine physicians' approach to deintensifying (reducing/stopping) or switching hypoglycemia-causing medications for older adults with type 2 diabetes. RESEARCH DESIGN AND METHODS: In this national survey, U.S. physicians in general medicine, geriatrics, or endocrinology reported changes they would make to hypoglycemia-causing medications for older adults in three scenarios: good health, HbA1c of 6.3%; complex health, HbA1c of 7.3%; and poor health, HbA1c of 7.7%. RESULTS: There were 445 eligible respondents (response rate 37.5%). In patient scenarios, 48%, 4%, and 20% of physicians deintensified hypoglycemia-causing medications for patients with good, complex, and poor health, respectively. Overall, 17% of physicians switched medications without significant differences by patient health. One-half of physicians selected HbA1c targets below guideline recommendations for older adults with complex or poor health. CONCLUSIONS: Most U.S. physicians would not deintensify or switch hypoglycemia-causing medications within guideline-recommended HbA1c targets. Physician preference for lower HbA1c targets than guidelines needs to be addressed to optimize deintensification decisions.
引用
- Pilla SJ, Jalalzai R, Tang O, et al. A National Physician Survey of Deintensifying Diabetes Medications for Older Adults With Type 2 Diabetes. Diabetes Care. 2023. PMID: 36800554. doi:10.2337/dc22-2146
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。